Quantitative pharmacologic MRI in mice
Identifieur interne : 000018 ( Main/Exploration ); précédent : 000017; suivant : 000019Quantitative pharmacologic MRI in mice
Auteurs : Teodora-Adriana Perles-Barbacaru [États-Unis] ; Daniel Procissi [États-Unis] ; Andrey V. Demyanenko [États-Unis] ; Russell E. Jacobs [États-Unis]Source :
- NMR in Biomedicine [ 0952-3480 ] ; 2012-04.
Abstract
Pharmacologic MRI (phMRI) uses functional MRI techniques to provide a noninvasive in vivo measurement of the hemodynamic effects of drugs. The cerebral blood volume change (ΔCBV) serves as a surrogate for neuronal activity via neurovascular coupling mechanisms. By assessing the location and time course of brain activity in mouse mutant studies, phMRI can provide valuable insights into how different behavioral phenotypes are expressed in deferring brain activity response to drug challenge. In this report, we evaluate the utility of three different intravascular ultrasmall superparamagnetic iron oxide (USPIO) contrast agents for phMRI using a gradient‐echo technique, with temporal resolution of one min at high magnetic field. The tissue half‐life of the USPIOs was studied using a nonlinear detrending model. The three USPIOs are candidates for CBV weighted phMRI experiments, with r2/r1 ratios ≥ 20 and apparent half‐lives ≥ 1.5 h at the described doses. An echo‐time of about 10 ms or longer results in a functional contrast to noise ratio (fCNR) > 75 after USPIO injection, with negligible decrease between 1.5‐2 h. phMRI experiments were conducted at 7 T using cocaine as a psychotropic substance and acetazolamide, a global vasodilator, as a positive control. Cocaine acts as a dopamine‐serotonin‐norepinephrine reuptake inhibitor, increasing extracellular concentrations of these neurotransmitters, and thus increasing dopaminergic, serotonergic and noradrenergic neurotransmission. phMRI results showed that CBV was reduced in the normal mouse brain after cocaine challenge, with the largest effects in the nucleus accumbens, whereas after acetazolamide, blood volume was increased in both cerebral and extracerebral tissue. Copyright © 2011 John Wiley & Sons, Ltd.
Url:
DOI: 10.1002/nbm.1760
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Quantitative pharmacologic MRI in mice</title>
<author><name sortKey="Perles Arbacaru, Teodora Driana" sort="Perles Arbacaru, Teodora Driana" uniqKey="Perles Arbacaru T" first="Teodora-Adriana" last="Perles-Barbacaru">Teodora-Adriana Perles-Barbacaru</name>
</author>
<author><name sortKey="Procissi, Daniel" sort="Procissi, Daniel" uniqKey="Procissi D" first="Daniel" last="Procissi">Daniel Procissi</name>
</author>
<author><name sortKey="Demyanenko, Andrey V" sort="Demyanenko, Andrey V" uniqKey="Demyanenko A" first="Andrey V." last="Demyanenko">Andrey V. Demyanenko</name>
</author>
<author><name sortKey="Jacobs, Russell E" sort="Jacobs, Russell E" uniqKey="Jacobs R" first="Russell E." last="Jacobs">Russell E. Jacobs</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:1901C568728015F2DEB89069C133555CE5F8A954</idno>
<date when="2012" year="2012">2012</date>
<idno type="doi">10.1002/nbm.1760</idno>
<idno type="url">https://api.istex.fr/document/1901C568728015F2DEB89069C133555CE5F8A954/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">000776</idno>
<idno type="wicri:Area/Main/Curation">000776</idno>
<idno type="wicri:Area/Main/Exploration">000018</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Exploration">000018</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Quantitative pharmacologic MRI in mice</title>
<author><name sortKey="Perles Arbacaru, Teodora Driana" sort="Perles Arbacaru, Teodora Driana" uniqKey="Perles Arbacaru T" first="Teodora-Adriana" last="Perles-Barbacaru">Teodora-Adriana Perles-Barbacaru</name>
<affiliation wicri:level="1"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Biological Imaging Center, Beckman Institute, California Institute of Technology, CA, 91125, Pasadena</wicri:regionArea>
<wicri:noRegion>Pasadena</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Procissi, Daniel" sort="Procissi, Daniel" uniqKey="Procissi D" first="Daniel" last="Procissi">Daniel Procissi</name>
<affiliation wicri:level="1"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Biological Imaging Center, Beckman Institute, California Institute of Technology, CA, 91125, Pasadena</wicri:regionArea>
<wicri:noRegion>Pasadena</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Demyanenko, Andrey V" sort="Demyanenko, Andrey V" uniqKey="Demyanenko A" first="Andrey V." last="Demyanenko">Andrey V. Demyanenko</name>
<affiliation wicri:level="1"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Biological Imaging Center, Beckman Institute, California Institute of Technology, CA, 91125, Pasadena</wicri:regionArea>
<wicri:noRegion>Pasadena</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Jacobs, Russell E" sort="Jacobs, Russell E" uniqKey="Jacobs R" first="Russell E." last="Jacobs">Russell E. Jacobs</name>
<affiliation wicri:level="1"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Biological Imaging Center, Beckman Institute, California Institute of Technology, CA, 91125, Pasadena</wicri:regionArea>
<wicri:noRegion>Pasadena</wicri:noRegion>
</affiliation>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Russell E. Jacobs, PhD. Caltech M/C 139–74, 1200 E. California Blvd. Pasadena</wicri:cityArea>
</affiliation>
<affiliation wicri:level="1"><country wicri:rule="url">États-Unis</country>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">NMR in Biomedicine</title>
<title level="j" type="abbrev">NMR Biomed.</title>
<idno type="ISSN">0952-3480</idno>
<idno type="eISSN">1099-1492</idno>
<imprint><publisher>John Wiley & Sons, Ltd</publisher>
<pubPlace>Chichester, UK</pubPlace>
<date type="published" when="2012-04">2012-04</date>
<biblScope unit="volume">25</biblScope>
<biblScope unit="issue">4</biblScope>
<biblScope unit="page" from="498">498</biblScope>
<biblScope unit="page" to="505">505</biblScope>
</imprint>
<idno type="ISSN">0952-3480</idno>
</series>
<idno type="istex">1901C568728015F2DEB89069C133555CE5F8A954</idno>
<idno type="DOI">10.1002/nbm.1760</idno>
<idno type="ArticleID">NBM1760</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0952-3480</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract">Pharmacologic MRI (phMRI) uses functional MRI techniques to provide a noninvasive in vivo measurement of the hemodynamic effects of drugs. The cerebral blood volume change (ΔCBV) serves as a surrogate for neuronal activity via neurovascular coupling mechanisms. By assessing the location and time course of brain activity in mouse mutant studies, phMRI can provide valuable insights into how different behavioral phenotypes are expressed in deferring brain activity response to drug challenge. In this report, we evaluate the utility of three different intravascular ultrasmall superparamagnetic iron oxide (USPIO) contrast agents for phMRI using a gradient‐echo technique, with temporal resolution of one min at high magnetic field. The tissue half‐life of the USPIOs was studied using a nonlinear detrending model. The three USPIOs are candidates for CBV weighted phMRI experiments, with r2/r1 ratios ≥ 20 and apparent half‐lives ≥ 1.5 h at the described doses. An echo‐time of about 10 ms or longer results in a functional contrast to noise ratio (fCNR) > 75 after USPIO injection, with negligible decrease between 1.5‐2 h. phMRI experiments were conducted at 7 T using cocaine as a psychotropic substance and acetazolamide, a global vasodilator, as a positive control. Cocaine acts as a dopamine‐serotonin‐norepinephrine reuptake inhibitor, increasing extracellular concentrations of these neurotransmitters, and thus increasing dopaminergic, serotonergic and noradrenergic neurotransmission. phMRI results showed that CBV was reduced in the normal mouse brain after cocaine challenge, with the largest effects in the nucleus accumbens, whereas after acetazolamide, blood volume was increased in both cerebral and extracerebral tissue. Copyright © 2011 John Wiley & Sons, Ltd.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Californie</li>
</region>
</list>
<tree><country name="États-Unis"><noRegion><name sortKey="Perles Arbacaru, Teodora Driana" sort="Perles Arbacaru, Teodora Driana" uniqKey="Perles Arbacaru T" first="Teodora-Adriana" last="Perles-Barbacaru">Teodora-Adriana Perles-Barbacaru</name>
</noRegion>
<name sortKey="Demyanenko, Andrey V" sort="Demyanenko, Andrey V" uniqKey="Demyanenko A" first="Andrey V." last="Demyanenko">Andrey V. Demyanenko</name>
<name sortKey="Jacobs, Russell E" sort="Jacobs, Russell E" uniqKey="Jacobs R" first="Russell E." last="Jacobs">Russell E. Jacobs</name>
<name sortKey="Jacobs, Russell E" sort="Jacobs, Russell E" uniqKey="Jacobs R" first="Russell E." last="Jacobs">Russell E. Jacobs</name>
<name sortKey="Jacobs, Russell E" sort="Jacobs, Russell E" uniqKey="Jacobs R" first="Russell E." last="Jacobs">Russell E. Jacobs</name>
<name sortKey="Procissi, Daniel" sort="Procissi, Daniel" uniqKey="Procissi D" first="Daniel" last="Procissi">Daniel Procissi</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Amerique/explor/CaltechV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000018 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000018 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Amerique |area= CaltechV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:1901C568728015F2DEB89069C133555CE5F8A954 |texte= Quantitative pharmacologic MRI in mice }}
This area was generated with Dilib version V0.6.32. |